Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.
Read the full article on the original site.
Read Full Article